Abstract: Epidermal Langerhans cells (LCs) and dermal dendritic cells (dDCs) capture cutaneous antigens and present them to T-cells in lymph nodes (LNs). The function of LCs and Langerin+ dDCs was extensively studied in the mouse, but their anatomical repartition is unknown. Here, we found LCs in back skin, footpads and tail skin of C57BL/6, BALB/c, 129/Sv and CBA/J mice. Langerin+ dDCs were readily observed in back skin of all strains, but only in footpads and tail of BALB/c and CBA/J mice. Similarly, while LCs were equally present in all LNs and strains, Langerin+ dDCs were found in popliteal LNs (draining footpads) only in BALB/c and CBA/J mice. The sciatic LNs, which we identified as the major tail-draining lymphoid organ, were devoid of Langerin+ dDCs in all strains. Thus, functionally different DCs reside in different skin areas, with variations among mouse strains, implying a potential impact on the cutaneous immune reaction.
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Background
Although they represent only a small proportion of total skin DCs, epidermal Langerhans cells (LCs) and Langerin+ dermal dendritic cells (dDCs) have been the subject of many functional studies in the mouse, discrepancies still exist as to their functional specialisation (1) (2) (3) (4) (5) (6) . LCs often appear tolerogenic, while Langerin+ dDCs have a critical role in cross-presentation of skin-derived antigens and type 1 T helper responses (3, 5, (7) (8) (9) .
Questions addressed
The anatomical repartition (10, 11) and strain-associated variations of Langerin+ DC subsets have not been thoroughly investigated, although such differences could have an important impact on the interpretation of results and better understanding of skin-specific immune responses. We analysed Langerin+ DC subsets in back skin, footpads and tail and in corresponding skin-draining LNs of C57BL/6, BALB/c, 129/Sv and CBA/J mouse strains.
Experimental design
Animals C57BL/6, CBA/J, 129/Sv and BALB/c mice (Charles River Laboratories France) were housed in specific pathogen-free conditions, and all experiments were carried out in conformity to the animal bioethics legislation.
Preparation of skin and LN cell suspensions
Back skin, footpad and tail skin as well as inguinal, popliteal, sciatic and mesenteric LNs were collected. Small pieces of tissues were incubated at 37°C in DMEM medium supplemented with 2% foetal calf serum (FCS; PAN-Biotech, Aidenbach, Germany), 1 mg/ml collagenase D, 1 mg/ml dispase II, 50 lg/ml DNAse I (all enzymes from Roche Diagnostics, Meylan, France) for 1 h (LNs) or 2 h (skin) on a shaker. 5 mM EDTA was added to stop enzymatic digestion, and cells were filtered through a 40 lm cell strainer (BD Biosciences).
Flow cytometry
All reactions were performed at 4°C for 20 min in PBS complemented with 2% FCS and 2.5 mM EDTA. Fc-receptors were blocked with 5 lg/ml CD16/CD32 antibody (2.4G2, BD, San Diego, CA, USA). Dead cells were excluded by labelling with Fixable Viability Dye (eBioscience, Frankfurt, Germany) in PBS for 30 min. Surface stainings were performed with 1 lg/ml of the following reagents: streptavidin-APC, anti-CD103-PE or -PerCP-Cy5.5 (M290), anti-CD11c-PerCP-Cy5.5 (N418) or -PE-Cy7 (HL3), anti-CD3-PE (145-2C11), anti-CD45-APC (30-F11; all from BD) and anti-CCR7-biotinylated (4B12, eBioscience) or their isotype controls. Cells were fixed, permeabilised (Cytofix/Cytoperm, BD) and labelled with 1 lg/ml anti-Langerin-FITC (929F3.01, Dendritics, Lyon, France). Flow cytometry was performed on a Gallios (BeckmanCoulter, Fullerton, CA, USA) and analysed with FlowJo (Treestar, Ashland, OR, USA).
Results
CD45+ CD11c+ skin DCs include CD103À EpCAM high Langerin+
LCs and CD103+ EpCAM low Langerin+ dDCs (1,2,7,9,12,13). We found LCs in all skin areas and mice studied (Fig. 1a) , but their proportion relative to CD11c+ DCs varied with their location (Fig. 1b) . LCs were abundant in back skin and footpads, but rare in tail. The low proportion of LCs in tail was confirmed by immunofluorescence on epidermal sheets (Figure S2a,b; 10 ). Compared to LCs, the percentage of Langerin+ dDCs was lower (Fig. 1a) , with a manifest variability across skin locations and mouse strains (Fig. 1c) . Indeed, while this DC subset was consistently found in back skin of all strains tested, it was only detectable in footpads of BALB/c and to a Variations in thickness and hairiness might impede uniform enzymatic digestion of the different skin areas. Because they are migratory, skin DCs can be isolated from skin-draining lymph nodes (LNs). However, the LNs that drain the tail remain unclearly defined (14) . We identified the sciatic LN as a major draining site for a coloured dye injected into the tail ( Figure S3a ). Mice with skin-draining LN hypertrophy (15,16) also had enlarged sciatic LNs ( Figure S3b ). Tg(Grm1)EPv mice that spontaneously develop melanomas on the tail (17) present with melanin-loaded sciatic LNs ( Figure S3c) . Finally, tail skin inflammation triggered by the TLR7 agonist imiquimod (18) or the irritant chemical dibutylphthalate (19) induced emigration of LCs into sciatic LNs (Figure S3d,e) .
We therefore studied inguinal (draining back skin), popliteal (footpads) and sciatic (tail) LNs, using mesenteric (intestine) LNs as a control. Skin-derived DCs were distinguished from LN-resident DCs by the expression of the chemokine receptor CCR7 that guides them upon emigration ( Fig. 2a; 20 ). LCs were found in all skin-draining LNs (Fig. 2b) , but the percentage of Langerin+ dDCs varied greatly and was in line with our analysis at skin level (Fig. 2c) . They were clearly present in inguinal LNs of all strains, in popliteal LNs of BALB/c and CBA/J mice only, and were totally absent from sciatic LNs in all strains.
Conclusions
While LCs are present in all skin types of all mouse strains, the distribution of Langerin+ dDCs appears site-and strain-specific. There was an absence of Langerin+ dDCs from footpads and popliteal LNs of C57BL/6 mice and 129/Sv and from tail and tail-draining LNs of all strains. The major tail-draining LNs were identified as the sciatic LNs based on a number of criteria including mobilisation by skin inflammation. Even upon skin DC mobilisation, no Langerin+ dDCs were observed in sciatic LNs. Inefficient hapten sensitisation on tail skin has been associated with the low density of LCs in this area (10) , but the lack of Langerin+ dDCs might contribute to this hyporesponsiveness (3) . A recent report suggested a complete absence of dDCs from footpads (11), but we found LangerinÀ dDCs in all sites investigated ( Figure S4 ).
Such differences among skin DC subsets are reminiscent of mouse-strain-specific expression of the endocytic receptor Langerin by LN-resident CD8+ DCs and gut DCs (21, 22) , and by the variations of plasmacytoid DC numbers linked to genetic polymorphisms (23, 24) . Footpads and the tail have a particularly protective stratum corneum, which might explain why immunosurveillance does not necessarily require the highly immunocompetent Langerin+ dDCs. Alternatively, a lack of Langerin+ dDCs could limit immune responses in these areas that are constantly subject to physical stress. Our findings strongly encourage side-by-side analyses of human DC subsets from different skin locations, that is areas exposed to UV or mechanical stress (25, 26) , and across ethnic groups. This may shed light on the frequencies of site-specific dermatitis or tumor formation in diverse genetic backgrounds. Finally, our results suggest new means to target specific DC subsets to manipulate the outcome of immunisation (27, 28) .
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